Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent

46.97
+0.12000.26%
Post-market: 46.970.00000.00%17:25 EDT
Volume:722.17K
Turnover:33.78M
Market Cap:2.32B
PE:-11.74
High:47.33
Open:47.01
Low:46.00
Close:46.85
Loading ...

Cogent Communications CEO to Present at Oppenheimer 28th Annual Technology, Internet & Communications Conference

Reuters
·
Yesterday

Cogent Biosciences Is Maintained at Buy by Citigroup

Dow Jones
·
19 Jul

Optimistic Buy Rating for Cogent Comms Amid Market Share Opportunities and Strategic Data Center Moves

TIPRANKS
·
18 Jul

Cogent Biosciences Currently Up 12 Consecutive Days, on Pace for Record Winning Streak -- Data Talk

Dow Jones
·
17 Jul

Cogent Communications Holdings Inc. to Release Second Quarter 2025 Earnings Results

Reuters
·
16 Jul

Major Investment Alert: Cogent Biosciences Stock Sees Multi-Million Dollar Purchase!

TIPRANKS
·
15 Jul

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
11 Jul

Cogent Biosciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
11 Jul

Cogent Biosciences 22.2M share Spot Secondary priced at $9.00

TIPRANKS
·
09 Jul

Cogent Biosciences Shares Fall After Public Offering News

Dow Jones
·
09 Jul

Press Release: Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock

Dow Jones
·
09 Jul

Cogent Biosciences Receives Buy Rating on Promising Trial Results and Market Potential

TIPRANKS
·
08 Jul

Cogent Biosciences Is Maintained at Outperform by Leerink Partners

Dow Jones
·
08 Jul

Cogent Biosciences Up Nearly 31%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
07 Jul

Cogent Biosciences price target raised to $18 from $16 at Leerink

TIPRANKS
·
07 Jul

Cogent Biosciences price target raised at Jefferies after ‘home run’ data

TIPRANKS
·
07 Jul

Jefferies Adjusts Price Target on Cogent Biosciences to $28 From $23, Maintains Buy Rating

MT Newswires Live
·
07 Jul

Cogent Biosciences trading halted, volatility trading pause

TIPRANKS
·
07 Jul

Cogent Biosciences Shares Rise After Mastocytosis Treatment Reaches Primary Endpoint in Recent Study

Dow Jones
·
07 Jul

Cogent Biosciences Announces Positive SUMMIT Trial Results

TIPRANKS
·
07 Jul